Evidence map›Paper›PMID 31036693›Full record

ArticleAntimicrobial agents and chemotherapy2019

Molecular Testing of Serial Blood Specimens from Patients with Early Lyme Disease during Treatment Reveals Changing Coinfection with Mixtures of Borrelia burgdorferi Genotypes.

Michael R Mosel, Heather E Carolan, Alison W Rebman, Steven Castro, Christian Massire, David J Ecker, Mark J Soloski, John N Aucott, Mark W Eshoo

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Laboratory Diagnosis of Lyme Borreliosis.Clinical microbiology reviews · 2021
    Review
  7. Review
  8. Article
  9. Mechanisms of Dysregulated Antibody Response in Lyme Disease.Frontiers in cellular and infection microbiology · 2020
    Article
  10. Review
  11. Lyme Disease Frontiers: ReconcilingPathogens (Basel, Switzerland) · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Michael R MoselIbis Biosciences, an Abbott Company, Carlsbad, California, USA.
Heather E CarolanIbis Biosciences, an Abbott Company, Carlsbad, California, USA.
Alison W RebmanDivision of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Steven CastroIbis Biosciences, an Abbott Company, Carlsbad, California, USA.
Christian MassireIbis Biosciences, an Abbott Company, Carlsbad, California, USA.
David J EckerIbis Biosciences, an Abbott Company, Carlsbad, California, USA.
Mark J SoloskiDivision of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
John N AucottDivision of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA jaucott2@jhmi.edu.
Mark W EshooIbis Biosciences, an Abbott Company, Carlsbad, California, USA.

Funding

Sample Processing and Immunoassay Research CoreP30AR070254 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI Antony Rosen · 2016 to 2026
$8.9M
NIAMS NIH HHS P30 AR070254
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsBorrelia burgdorferiGenotypeHumansLyme DiseasePolymerase Chain ReactionSpectrometry, Mass, Electrospray IonizationAnti-Bacterial AgentsantibioticBorrelia burgdorferigenotypeLyme diseasetime course

Identifiers

PMID31036693
PMCPMC6591639

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.